JSPR EPS Estimates
Jasper Therapeutics, Inc.
$0.57
+$0.01(+1.27%)
31
Overall
60
Value
10
Tech
23
Quality
Market Cap
$18.63M
Volume
180.74K
52W Range
$0.32 - $2.69
Target Price
$6.50
JSPR EPS estimates: the consensus estimate for Jasper Therapeutics, Inc.'s current fiscal year is -$1.14 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
JSPR EPS Estimates
- EPS estimate, current quarter
- $-0.08
- EPS estimate, next quarter
- $-0.44
- EPS estimate, current year
- $-1.14
- EPS estimate, next year
- $-0.72
- EPS growth, 3-year
- +27.35%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.95 |
| 2024 | $-4.89 |
| 2023 | $-6.18 |
| 2022 | $-10.30 |
| 2021 | $-26.90 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JSPR | $0.57 | +1.3% | 180.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jasper Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW